(Q69925917)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

title

Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference

1 reference

C J Mulder

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

G N Tytgat

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

I T Weterman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

W Dekker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

P Blok

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

M Schrijver

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

H van der Heide

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

language of work or name

English

0 references

publication date

1 December 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

page(s)

1449-1453

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

Sulphasalazine and salicylazosulphadimidine in ulcerative colitis

7 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

An experiment to determine the active therapeutic moiety of sulphasalazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

Comparison of beclomethasone dipropionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

A complication of SASP therapy: hair loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

5-Aminosalicylic acid in the treatment of Crohn's disease. A 16-week double-blind, placebo-controlled, multicentre study with Pentasa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

Pentasa in lieu of sulfasalazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

10.1016/S0016-5085(88)80061-1

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference